Avril Chester, Chief Technology Officer

Professional Overview

Avril Chester is a seasoned technology leader with extensive experience driving digital transformation and innovation within the pharmaceutical and healthcare sectors. As the Chief Technology Officer at the Royal Pharmaceutical Society, she is responsible for spearheading the organization's technology strategy, overseeing the implementation of cutting-edge solutions, and fostering a culture of technological excellence.

Experience Summary

Current Role

Avril has served as the Chief Technology Officer at the Royal Pharmaceutical Society since June 2022. In this role, she is responsible for aligning the organization's technology initiatives with its strategic objectives, ensuring the seamless integration of digital tools and platforms across the society's operations. Avril's expertise in leveraging technology to enhance organizational efficiency and member experience has been instrumental in driving the Royal Pharmaceutical Society's digital transformation efforts.

Career Progression

Prior to her current role, Avril was the Founder of Cancer Central UK, a pioneering non-profit organization focused on leveraging technology to improve cancer care and support. During her tenure, she spearheaded the development of innovative digital platforms and tools that empowered patients, caregivers, and healthcare providers. Avril also served as the Chief Technology Officer at the Royal Institute of British Architects (RIBA), where she led the organization's digital transformation and oversaw the implementation of cutting-edge technologies to enhance member services and operational efficiency.

Earlier in her career, Avril held the position of Director at Kaniave Limited, a technology consulting firm, where she advised clients across various industries on digital strategy and technology implementation. She also served as the Vice Chair and Board Trustee at The Advocacy People, a charitable organization dedicated to empowering individuals and communities.

Academic Background

Avril holds a Bachelor of Science (BSc) degree in Computer Science from the University of Cambridge, where she graduated with distinction. Her academic achievements and passion for technology have been the foundation for her successful career in the industry.

Areas of Expertise

Avril's areas of expertise span a wide range of technology domains, including cloud computing, data analytics, cybersecurity, and user experience design. She is adept at leveraging emerging technologies to drive organizational transformation and enhance operational efficiency. Additionally, Avril's strong leadership skills and strategic vision have enabled her to spearhead complex technology initiatives and foster collaborative, high-performing teams.

Professional Impact

Throughout her career, Avril has made significant contributions to the technology landscape within the pharmaceutical and healthcare sectors. Her work at Cancer Central UK has been widely recognized for its innovative approach to improving cancer care through digital solutions, and her leadership at the Royal Pharmaceutical Society and RIBA has been instrumental in advancing the organizations' digital capabilities and delivering enhanced value to their respective stakeholders.

Conclusion

Avril Chester is a dynamic and accomplished technology leader with a proven track record of driving digital transformation and innovation within the pharmaceutical and healthcare industries. Her deep technical expertise, strategic vision, and strong leadership skills have positioned her as a valuable asset to the organizations she has served. As the Chief Technology Officer at the Royal Pharmaceutical Society, Avril is poised to continue making a meaningful impact on the industry, leveraging technology to enhance the delivery of healthcare services and improve patient outcomes.